Supplement Claims For Drug/Therapy Augmentation Clarified By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA is pulling back slightly from its proposed stance restricting dietary supplement claims for augmentation of drugs or therapies in the structure/function claims final rule published Jan. 6. However, the agency continues to believe such claims should not refer specifically to a disease.